Paper36980228
Terminal Complement Activation Is Induced by Factors Released from Endplate Tissue of Disc Degeneration Patients and Stimulates Expression of Catabolic Enzymes in Annulus Fibrosus Cells.
Kuhn A and 6 others. Cells, 2023. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Terminal Complement Activation Is Induced by Factors Released from Endplate Tissue of Disc Degeneration Patients and Stimulates Expression of Catabolic Enzymes in Annulus Fibrosus Cells. Papers, record 36980228. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980228
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Terminal Complement Activation Is Induced by Factors Released from Endplate Tissue of Disc Degeneration Patients and Stimulates Expression of Catabolic Enzymes in Annulus Fibrosus Cells.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Annulus Fibrosus | Major topic |
| Intervertebral Disc Degeneration | Major topic |
| Intervertebral Disc | Major topic |
| Humans | |
| Matrix Metalloproteinase 1 | |
| Cyclooxygenase 2 | |
| Zymosan | |
| Complement Activation |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12394896 | Changes in mRNA and protein levels of proteoglycans of the anulus fibrosus and nucleus pulposus during intervertebral disc degeneration. | Spine (Phila Pa 1976) | 2002 | https://conductscience.org/library/papers/12394896 | PubMed |
| 2 | 16915105 | What is intervertebral disc degeneration, and what causes it? | Spine (Phila Pa 1976) | 2006 | https://conductscience.org/library/papers/16915105 | PubMed |
| 3 | 19730437 | Complement regulators and inhibitory proteins. | Nat Rev Immunol | 2009 | https://conductscience.org/library/papers/19730437 | PubMed |
| 4 | 24831500 | Molecular interactions between human cartilaginous endplates and nucleus pulposus cells: a preliminary investigation. | Spine (Phila Pa 1976) | 2014 | https://conductscience.org/library/papers/24831500 | PubMed |
| 5 | 30941658 | Systematic Review of Decision Analytic Modelling in Economic Evaluations of Low Back Pain and Sciatica. | Appl Health Econ Health Policy | 2019 | https://conductscience.org/library/papers/30941658 | PubMed |
| 6 | 21598302 | Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β. | J Cell Biochem | 2011 | https://conductscience.org/library/papers/21598302 | PubMed |
| 7 | 22795972 | New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties. | Immunobiology | 2013 | https://conductscience.org/library/papers/22795972 | PubMed |
| 8 | 29434479 | Osteoarthritis and the Complement Cascade. | Clin Med Insights Arthritis Musculoskelet Disord | 2018 | https://conductscience.org/library/papers/29434479 | PubMed |
| 9 | 15564919 | Nutrition of the intervertebral disc. | Spine (Phila Pa 1976) | 2004 | https://conductscience.org/library/papers/15564919 | PubMed |
| 10 | 25956457 | The membrane attack complex as an inflammatory trigger. | Immunobiology | 2016 | https://conductscience.org/library/papers/25956457 | PubMed |
| 11 | 23738544 | Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23738544 | PubMed |
| 12 | 21646416 | Lumbar disc degeneration and genetic factors are the main risk factors for low back pain in women: the UK Twin Spine Study. | Ann Rheum Dis | 2011 | https://conductscience.org/library/papers/21646416 | PubMed |
| 13 | 31981738 | Crucial role of the terminal complement complex in chondrocyte death and hypertrophy after cartilage trauma. | Osteoarthritis Cartilage | 2020 | https://conductscience.org/library/papers/31981738 | PubMed |
| 14 | 35598724 | Involvement of complement peptides C3a and C5a in osteoarthritis pathology. | Peptides | 2022 | https://conductscience.org/library/papers/35598724 | PubMed |
| 15 | 22057346 | Identification of a central role for complement in osteoarthritis. | Nat Med | 2011 | https://conductscience.org/library/papers/22057346 | PubMed |
| 16 | 28671713 | Complement C5a-Induced Changes in Neutrophil Morphology During Inflammation. | Scand J Immunol | 2017 | https://conductscience.org/library/papers/28671713 | PubMed |
| 17 | 12544925 | Complement membrane attack complexes in pathologic disc tissues. | Spine (Phila Pa 1976) | 2003 | https://conductscience.org/library/papers/12544925 | PubMed |
| 18 | 29752310 | Extracellular Histones Inhibit Complement Activation through Interacting with Complement Component 4. | J Immunol | 2018 | https://conductscience.org/library/papers/29752310 | PubMed |
| 19 | 32210719 | The Immune Privilege of the Intervertebral Disc: Implications for Intervertebral Disc Degeneration Treatment. | Int J Med Sci | 2020 | https://conductscience.org/library/papers/32210719 | PubMed |
| 20 | 21777704 | Proteases involved in cartilage matrix degradation in osteoarthritis. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/21777704 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41865378 | Protocol to quantify cell-surface vimentin on senescent human chondrocytes and other cell types via a cell-based ELISA. | STAR Protoc | 2026 | https://conductscience.org/library/papers/41865378 | PubMed |
| 41440568 | How Safe Are Oxygen-Ozone Therapy Procedures for Spine Disc Herniation? The SIOOT Protocols for Treating Spine Disorders. | J Imaging | 2025 | https://conductscience.org/library/papers/41440568 | PubMed |
| 41372752 | Do microenvironmental changes in degenerative disc disease reflect in systemic circulation? A proteomic investigation. | Clin Proteomics | 2025 | https://conductscience.org/library/papers/41372752 | PubMed |
| 39877352 | Terminal complement complex deposition on chondrocytes promotes premature senescence in age- and trauma-related osteoarthritis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39877352 | PubMed |
| 39200157 | Analysis of Intervertebral Disc Degeneration Induced by Endplate Drilling or Needle Puncture in Complement C6-Sufficient and C6-Deficient Rabbits. | Biomedicines | 2024 | https://conductscience.org/library/papers/39200157 | PubMed |
| 38312949 | The role of the complement system in disc degeneration and Modic changes. | JOR Spine | 2024 | https://conductscience.org/library/papers/38312949 | PubMed |
| 38179277 | Current status and development direction of immunomodulatory therapy for intervertebral disk degeneration. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/38179277 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36980228
GET https://conductscience.org/api/papers/v1/36980228/references?page=2